In this study, functional enrichment analysis revealed that targets such as CD63, IL17RA, and IL1R1 are involved in depression-related pathways, including the HIF-1, MAPK, and PI3K-Akt signaling pathways. Here, CD63 is linked to depressive symptom measurement.